by Usha Govindarajulu | Apr 27, 2022 | Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
April 27, 2022 In a very interesting recent article that appeared in the Harvard Gazette on April 21, attention is brought to the negative effect of the COVID-19 pandemic on childrens’ mental health. The article appears to be focused on surveys done in 1999, 2004,...
by Usha Govindarajulu | Apr 13, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
Issues in COVID-19 research and statistical analyses (Part XVVVIII) April 13, 2022 In one of the latest Scientific American article, “What We Know about Omicron’s BA.2 Variant So Far”, the article summarizes some of the latest research about this new COVID-19 variant,...
by Usha Govindarajulu | Mar 30, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 30, 2022 Latest research published in the Lancet shows diabetes onset was higher for those with post-acute sequelae or long-haul COVID-19 however these may be preliminary results. The results came from a cohort study which used databases from the United States...
by Usha Govindarajulu | Mar 16, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
March 15, 2022 In a recent article in The Scientist than appeared back in January, they mentioned using several pre-print articles which are cited for this article. In one of the pre-print articles by Adamson et al published on March 5 about a very recent small study...
by Usha Govindarajulu | Jan 7, 2022 | Biostatistics, Blog, COVID-19, Healtcare
January 5, 2022 With the ongoing rise in COVID-19 cases due to the Omicron variant of Sars-Cov-2, we searched for some actual studies on the change in vaccine efficacy due to Omicron exposure. In one pre-print article, Buchan et al studied 3,442...
by Usha Govindarajulu | Nov 26, 2021 | Biostatistics, Blog, COVID-19, Healtcare, Professor, Usha Govindarajulu
At home Antigen tests statistical results November 24, 2021 Antigen tests for SARS-CoV-2 are back and are pending more approvals by the current administration. If so, they may be used more often and more frequently to help people get back to a more normal lifestyle....
